Latest News

NOVADOZ PHARMACEUTICALS: FDA Approvals of Oseltamivir and Dofetilide Continues the Company's Rise in the Generic Market

Novadoz Pharmaceuticals, the U.S based sales & marketing affiliate for MSN Labs, located in Hyderabad India, recently received FDA approval for their generic versions of Oseltamivir Phosphate Capsules and Dofetilide Capsules.

UNIVERSAL PACKAGING: Shifts Focus to COVID-19 Solutions by Providing FDA-Approved Face Masks

Leading Provider to National Pharmaceutical and Long-Term Care Industries Has 3-Ply Surgical and KN95 Masks In Stock, Ready to Ship Same Day.

FDA: Coronavirus (COVID-19) Update: FDA Publicly Shares Antibody Test Performance Data From Kits as Part of Validation Study

U.S. Food and Drug Administration publicly posted test performance data from four more antibody, or serology, test kits on open.fda.gov from its independent performance validation study effort with the National Institutes of Health’s (NIH) National Cancer Institute (NCI)

FDA: Federal judge enters order of permanent injunction against New York company for distributing unapproved drugs

A federal judge has ordered two individuals doing business as Sundial Herbal Products to stop distributing unapproved new drugs and misbranded drugs until they comply with federal law.

GENENTECH: FDA Approves Genentech’s Tecentriq in Combination With Avastin for People With the Most Common Form of Liver Cancer

Tecentriq in combination with Avastin is the first and only cancer immunotherapy regimen approved for the treatment of unresectable or metastatic hepatocellular carcinoma

LETSGETCHECKED: Debuts FDA EUA-Authorized At-Home Coronavirus (COVID-19) Sure-track Test

FDA EUA-authorized at-home Coronavirus test is now available in the United States, offering unparalleled safety and scale for consumers

FDA: Coronavirus (COVID-19) Update: FDA Takes Steps to Streamline Development of Tests With At-Home Sample Collection

The U.S. Food and Drug Administration took steps to further support the development of COVID-19 tests for at-home self-collection by including a voluntary EUA template for at-home sample collection kits to its website.

QUEST DIAGNOSTICS: FDA Authorizes Quest Diagnostics COVID-19 Nasal Specimen Self-Collection Kit for Emergency Use

Company to make the device available through broad range of healthcare, state, employer and consumer-initiated channels

PROTALIX BIOTHERAPEUTICS: Protalix BioTherapeutics and Chiesi Global Rare Diseases Announce Submission of Biologics License Application to U.S. Food and Drug Administration for Pegunigalsidase Alfa for the Treatment of Fabry Disease

Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system, or the Company, together with its development and commercialization partner Chiesi Global Rare Diseases, a unit of Chiesi, an international research-focused healthcare group, today announced the submission on May 27, 2020 of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for pegunigalsidase alfa for the proposed treatment of adult patients with Fabry disease via the FDA's Accelerated Approval pathway.

FDA: Coronavirus (COVID-19) Update: FDA Provides New Tool to Aid Development and Evaluation of Diagnostic Tests That Detect SARS-CoV-2 Infection

The U.S. Food and Drug Administration took a new step to support the agency’s evaluation of diagnostic tests for COVID-19, by providing a SARS-CoV-2 reference panel.

EXPRESSION THERAPEUTICS: Announces IND Approval by the FDA for Hemophilia A Gene Therapy

Expression Therapeutics has announced that it has received clearance by the United States Food and Drug Administration (FDA) to proceed following review of its Investigational New Drug Application (IND) for clinical testing of its novel lentiviral vector-based gene therapy — ET3 — for hemophilia A.

ORTEQ® SPORTS MEDICINE: Announces Publication of 5-year Multi- Center Clinical Data for the Actifit® Meniscal Scaffold in the American Journal of Sports Medicine (AJSM), Receives FDA Breakthrough Device Designation

Orteq Sports Medicine Ltd. (www.orteq.com), a developer of joint preservation solutions for orthopedic patients, announces 5-year, multi center, peer-reviewed data published in the AJSM analyzing the Actifit meniscal scaffold that shows more than 87% survival rates with increased knee function and reduced pain.

SMART MEDICAL SYSTEMS: Receives FDA Clearance for Its G-EYE® Colonoscope

SMART's G-EYE® Colonoscope, incorporating the G-EYE® Balloon Technology which helps control the endoscope's field of view and positioning during colonoscopy, was cleared for marketing in the USA by FDA

HIKMA: Receives FDA approval for its generic Vascepa®

Hikma Pharmaceuticals PLC (Hikma), the multinational generic pharmaceutical company, today announces that its wholly owned U.S. subsidiary Hikma Pharmaceuticals USA Inc. has received approval from the US Food and Drug Administration (FDA) for its Icosapent Ethyl Capsules, 1 gm, the generic equivalent to Vascepa®.

LGMA: Leafy Greens Marketing Agreement to Use Clues from FDA Report to Prevent Future Outbreaks

California leafy greens growers are pledging to incorporate findings from a report issued today by the U.S. Food and Drug Administration (FDA) into its ongoing process to strengthen required food safety practices on farms.

FDA: Releases Report on Investigation into Fall 2019 Outbreaks of Illnesses Tied to Romaine Lettuce

As the nation grapples with the COVID-19 public health emergency, the U.S. Food and Drug Administration is grateful for all that the food and agricultural sector is doing to provide safe and available food to consumers during this difficult time.

MARENA: Georgia-Based Healthcare Manufacturer, Marena, to Supply Poll Workers With FDA-Approved Face Masks Ahead of June Primary

The Marena Group LLC, a Georgia-based medical device manufacturer, announced that they will be supplying Georgia election and poll officers with 35,000 masks for protection against COVID-19.

FDA: Feed Your Mind with FDA's New Education Initiative on Genetically Engineered Foods

The U.S. Food and Drug Administration (FDA), with the U.S. Department of Agriculture (USDA) and U.S. Environmental Protection Agency (EPA), launched Feed Your Mind, a new Agricultural Biotechnology Education and Outreach Initiative. The Initiative aims to increase consumer awareness and understanding of genetically engineered foods or GMOs.

FDA Reporter